ALX Oncology Holdings Inc. (ALXO) Misses Q4 EPS by 7c

ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q4 EPS of ($0.42), $0.07 worse than the analyst estimate of ($0.35).

For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.

You May Also Be Interested In

• BlackRock’s Rosenberg says inflation data key after jobs beat
• StoneX on Mama’s Creations (MAMA): 'We Remain High-Conviction Buyers'
• Blue Owl Is Said To Plan Public Company For Data Center Roll-up - Bloomberg